Clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabineGiulio Metro, Stefania Gori, Jennifer Foglietta et al.|Annals of Oncology|2010Cited by 168
A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective studyFlavia Novelli, Marcella Mottolese|Breast Cancer Research|2008Cited by 107
HER2 Protein and Gene Variation between Primary and Metastatic Breast Cancer: Significance and Impact on Patient CareAlessandra Fabi, Marcella Mottolese, Anna Di Benedetto et al.|Clinical Cancer Research|2011Cited by 98
A phase II study on metastatic breast cancer patients treated with weekly vinorelbine with or without trastuzumab according to HER2 expression: changing the natural history of HER2-positive diseasePaola Papaldo, F. Cognetti, Alessandra Fabi et al.|Annals of Oncology|2006Cited by 82
Functional and prognostic significance of the genomic amplification of frizzled 6 (<i><scp>FZD6</scp></i>) in breast cancerGabriele Corda, Arturo Sala, Gianluca Sala et al.|The Journal of Pathology|2016Cited by 74